Cargando…
Omidenepag, a Selective, Prostanoid EP2 Agonist, Does Not Suppress Adipogenesis in 3D Organoids of Human Orbital Fibroblasts
PURPOSE: The purpose of this study was to present the effects of the prostanoid EP2 agonist, omidenepag (OMD) on human orbital fibroblasts (HOFs) using a three-dimension (3D) cell culture. METHODS: During adipogenesis of 3D HOFs organoids, changes in size, lipids staining, mRNA expression of adipoge...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039573/ https://www.ncbi.nlm.nih.gov/pubmed/34003984 http://dx.doi.org/10.1167/tvst.10.4.6 |